Asahi Kasei Corp. is to launch in December a DKK6 ($0.88) per share voluntary tender offer for Veloxis Pharmaceuticals AS (formerly LifeCycle Pharma), a one-product company focused on post-transplant therapy.
The move, which Veloxis said followed a strategic review and competitive bidding process, has been prompted by the large diversified...








